scholarly article | Q13442814 |
P50 | author | David W Dunne | Q30513910 |
Klaudia Walter | Q37371637 | ||
Birgitte J Vennervald | Q41047434 | ||
Narcis B Kabatereine | Q56762863 | ||
Joseph K Mwatha | Q115100940 | ||
Gachuhi Kimani | Q115100943 | ||
P2093 | author name string | Sarah Joseph | |
Frances M Jones | |||
Anthony J C Fulford | |||
John H Ouma | |||
H Curtis Kariuki | |||
Rowena McBeath | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Schistosoma mansoni | Q2324689 |
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 5490-5498 | |
P577 | publication date | 2006-10-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens | |
P478 | volume | 177 |
Q80290782 | Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis |
Q28541675 | An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas |
Q28475501 | Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE |
Q35088439 | Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil |
Q62486477 | Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity |
Q35751348 | CD4+CD25hiFOXP3+ Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel |
Q24657733 | Current status of vaccines for schistosomiasis |
Q38853774 | DEWORMING DELUSIONS? MASS DRUG ADMINISTRATION IN EAST AFRICAN SCHOOLS. |
Q34500892 | Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray |
Q53697118 | Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses. |
Q33419492 | Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial |
Q37627668 | Effects of maternal worm infections and anthelminthic treatment during pregnancy on infant motor and neurocognitive functioning |
Q36506153 | Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections |
Q34413522 | Human schistosomiasis |
Q35000247 | Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour |
Q37191336 | Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4. |
Q34782228 | Immunology of human schistosomiasis |
Q33611746 | Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases |
Q37464180 | Longitudinal analysis of antigen specific response in individuals with Schistosoma mansoni infection in an endemic area of Minas Gerais, Brazil |
Q36010705 | Multivariable Regression Analysis in Schistosoma mansoni-Infected Individuals in the Sudan Reveals Unique Immunoepidemiological Profiles in Uninfected, egg+ and Non-egg+ Infected Individuals |
Q37994231 | Parasite glycans and antibody-mediated immune responses in Schistosoma infection |
Q64443565 | Population level changes in schistosome-specific antibody levels following chemotherapy |
Q33596079 | Posttreatment changes in cytokines induced by Schistosoma mansoni egg and worm antigens: dissociation of immunity- and morbidity-associated type 2 responses |
Q36396801 | Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis? |
Q34654313 | Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils |
Q56909282 | S. mansoni Schistosomula Antigens Induce Th1/Proinflammatory Cytokine Responses |
Q61415127 | Schistosoma mansoni schistosomula antigens induce Th1/Pro-inflammatory cytokine responses |
Q35130094 | Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection |
Q34249973 | Suppression of basophil histamine release and other IgE-dependent responses in childhood Schistosoma mansoni/hookworm coinfection |
Q60949688 | Systemic Cytokine and Chemokine Profiles in Individuals With Infection and Low Parasite Burden |
Q37014921 | T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment |
Q57152572 | The Interdependence between Schistosome Transmission and Protective Immunity |
Q38871350 | Understanding ethnic differences in behaviour relating to Schistosoma mansoni re-infection after mass treatment |
Search more.